[CYCC] YoY Annual Result on 31-Dec-2008 [#FY]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
31-Mar-2009
Financial Year
2008
Quarter
31-Dec-2008 [#FY]
Profit Trend
YoY- -67.90%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Annual Result
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
Revenue 699 686 911 877 129 387 813 -2.48%
PBT -15,808 -16,678 -20,518 -42,135 -26,094 -31,503 -37,088 -13.24%
Tax -565 -657 -948 -1,749 -2,041 -2,245 -274 12.81%
NP -15,243 -16,021 -19,570 -40,386 -24,053 -29,258 -29,416 -10.37%
Tax Rate - - - - - - - -
Total Cost 15,942 16,707 20,481 41,263 24,182 29,645 30,229 -10.11%
Ratio Analysis
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
NP Margin -2,180.69 -2,335.42 -2,148.19 -4,605.02 -18,645.74 -7,560.21 -3,618.20 -8.08%
Per Share
31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 CAGR
EPS -509.10 -711.22 -1,481.23 -3,320.67 -2,033.39 -3,671.02 -7,424.53 -36.01%
EPS Diluted -509.10 -711.22 -1,481.23 -3,320.67 -2,033.39 -3,671.02 -7,424.53 -36.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.